Oviva Company

Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform. They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allows patients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions. Oviva was founded in 2013 and is based in London, England.
Technology: AgeTech
Industry: P4 Medicine
Headquarters: London
Founded Date: 2013-01-01
Employees Number: 251-500
Funding Status: Late Stage Venture
Investors Number: 10
Total Funding: $127,481,679
Estimated Revenue: $1M to $10M
Last Funding Type: Series C

Visit Website
contact_uk@oviva.com
https://twitter.com/OvivaHealth
Register and Claim Ownership